Chiron Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58M | Sell |
|
|||||
|
2025
Q1 | $6.8M | Sell |
|
|||||
|
2024
Q4 | $7.85M | Sell |
|
|||||
|
2024
Q3 | $8.78M | Sell |
|
|||||
|
2024
Q2 | $8.47M | Sell |
|
|||||
|
2024
Q1 | $8.74M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $10.9M | Buy |
|
|||||
|
2023
Q2 | $11.5M | Sell |
|
|||||
|
2023
Q1 | $12.8M | Buy |
|
|||||
|
2022
Q4 | $12.4M | Sell |
|
|||||
|
2022
Q3 | $12.6M | Sell |
|
|||||
|
2022
Q2 | $12.4M | Buy |
|
|||||
|
2022
Q1 | $14.2M | Buy |
|
|||||
|
2021
Q4 | $5.07M | Buy |
|
|||||
|
2021
Q3 | $4.97M | Buy |
|
|||||
|
2021
Q2 | $1.15M | Buy |
|
|||||
|
2021
Q1 | $382K | Buy |
|
|||||
|
2020
Q4 | $325K | Sell |
|
|||||
|
2020
Q3 | $445K | Buy |
|